Loading…
Regencell Bioscience Holdings Limited is projected to decline to $5.75 by 2027, a -2% move from its current price of $5.88. RGC is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $5.33 | $5.88 | $6.48 | -0.03% |
| Jul 14 | $5.12 | $5.88 | $6.75 | -0.06% |
| Jul 15 | $4.96 | $5.87 | $6.96 | -0.09% |
| Jul 16 | $4.83 | $5.87 | $7.14 | -0.11% |
| Jul 17 | $4.72 | $5.87 | $7.31 | -0.14% |
| Jul 18 | $4.62 | $5.87 | $7.46 | -0.17% |
| Jul 19 | $4.53 | $5.87 | $7.60 | -0.20% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.53 | $5.87 | $7.60 | -0.20% |
| Week 2 | $4.06 | $5.86 | $8.45 | -0.40% |
| Week 3 | $3.73 | $5.85 | $9.16 | -0.59% |
| Week 4 | $3.47 | $5.83 | $9.79 | -0.79% |
| Week 5 | $3.26 | $5.82 | $10.39 | -0.99% |
| Week 6 | $3.08 | $5.81 | $10.96 | -1.19% |
| Week 7 | $2.92 | $5.80 | $11.51 | -1.38% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder.
The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Regencell Bioscience is categorized under Healthcare and operates within the Healthcare sector.
Regencell Bioscience Holdings Limited (RGC) is trading at $6.00, with a market capitalization of $2.96B, and a market rank of 1745.
The stock carries notable risk, reflected in an annualized volatility of 200%.
Forecasts show a path from 2026 with an average price near $6.00 and a long-term rise toward 2032-2050, including a 2029 average of $4.61, a 2030 average of $5.17, and a 2040 average of $9.31, with a 2050 average of $13.90. The implied ROIs vary, from -23.1% in 2029 to 131.9% by 2050.
A major floor 4.6% below — a decisive break under it would weaken the trend.
The nearest floor, 4.6% below — buyers have tended to step in here.
The nearest ceiling, 311.1% above — a clean break opens room to run.
A major ceiling 473.5% above — clearing it would confirm fresh momentum.
Key RGC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of RGC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.00 | Sell | $6.17 | Sell |
| MA 10 | $6.32 | Sell | $7.10 | Sell |
| MA 20 | $10.00 | Sell | $10.09 | Sell |
| MA 50 | $19.46 | Sell | $16.52 | Sell |
| MA 100 | $23.36 | Sell | $20.21 | Sell |
| MA 200 | $21.96 | Sell | $20.23 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 24.93 | Buy |
| Stoch RSI (14) | 89.94 | Sell |
| CCI (20) | -67.34 | Neutral |
| Williams %R (14) | -95.06 | Info |
| MACD (12,26,9) | 0.20 | Buy |
| ROC (12) | -46.93 | Sell |
| Bollinger %B (20,2) | 0.28 | Neutral |
| Stochastic %K (14) | 4.94 | Buy |
| TRIX (15) | -3.59 | Sell |
| Awesome (5,34) | -9.42 | Sell |
| Ultimate (7,14,28) | 37.85 | Neutral |
| Momentum (10) | -1.61 | Sell |
| Aroon Osc (25) | -84.00 | Sell |
| Hull MA (9) | 5.94 | Sell |
| ADX (14) | 47.78 | Sell |
| ATR (14) | 0.95 | Info |
The 30-day sentiment is NEUTRAL, and RSI14 is 20.
SMA50 is $19.46 and SMA200 is $21.96, providing near-term trend references."
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.61 | $5.88 | $7.83 | 0% | Neutral | |
| $4.17 | $5.75 | $8.57 | -2% | Neutral | |
| $3.53 | $5.18 | $8.22 | -12% | Neutral | |
| $2.93 | $4.52 | $7.54 | -23% | Bearish | |
| $3.14 | $5.08 | $8.81 | -14% | Neutral | |
| $3.68 | $6.21 | $11.16 | +6% | Neutral | |
| $4.16 | $7.33 | $13.57 | +25% | Bullish | |
| $3.91 | $7.18 | $13.67 | +22% | Bullish | |
| $3.28 | $6.27 | $12.24 | +7% | Neutral | |
| $3.46 | $6.88 | $13.74 | +17% | Neutral | |
| $4.11 | $9.13 | $20.04 | +55% | Bullish | |
| $6.13 | $13.62 | $31.32 | +132% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $5.61 | $5.88 | $7.02 | +0.00% |
| August 2026 | $4.82 | $5.83 | $7.36 | -0.78% |
| September 2026 | $4.66 | $5.73 | $7.38 | -1.79% |
| October 2026 | $4.32 | $5.37 | $7.03 | -6.32% |
| November 2026 | $4.33 | $5.45 | $7.24 | +1.47% |
| December 2026 | $4.58 | $5.81 | $7.83 | +6.74% |
Click any year to see its month-by-month RGC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The RGC price prediction for 2026 points to an average of $5.88 (low $5.61, high $7.83) — a potential gain of 0% on today's $5.88. A consolidation phase looks the most probable path here.
In 2027, RGC is projected to trade between $4.17 and $8.57, averaging $5.75 — a potential decline of -2% from today's $5.88. That is -2% versus the projected 2026 average. Price action looks broadly range-bound.
Regencell Bioscience Holdings Limited's 2028 outlook centres on $5.18, within a $3.53 to $8.22 range. That is -10% versus the projected 2027 average. That marks a -12% change versus current levels. A consolidation phase looks the most probable path here.
By 2029, RGC could reach as high as $7.54, with a base case around $4.52 and support toward $2.93 — roughly -23% from $5.88. A cyclical pullback looks likely — prices rarely move in a straight line.
Expect RGC to range from $3.14 to $8.81 through 2030. The $5.08 average target implies a -14% move from current prices. That is up +12% on the projected 2029 average. A consolidation phase looks the most probable path here.
The RGC price prediction for 2031 points to an average of $6.21 (low $3.68, high $11.16) — a potential gain of +6% on today's $5.88. Price action looks broadly range-bound.
In 2032, RGC is projected to trade between $4.16 and $13.57, averaging $7.33 — a potential gain of +25% from today's $5.88. That is up +18% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Regencell Bioscience Holdings Limited's 2033 outlook centres on $7.18, within a $3.91 to $13.67 range. That is -2% versus the projected 2032 average. That marks a +22% change versus current levels. Momentum favours further upside here.
By 2034, RGC could reach as high as $12.24, with a base case around $6.27 and support toward $3.28 — roughly +7% from $5.88. A consolidation phase looks the most probable path here.
Expect RGC to range from $3.46 to $13.74 through 2035. The $6.88 average target implies a +17% move from current prices. That is up +10% on the projected 2034 average. Price action looks broadly range-bound.
The RGC price prediction for 2040 points to an average of $9.13 (low $4.11, high $20.04) — a potential gain of +55% on today's $5.88. Buyers look set to stay in control over this stretch.
In 2050, RGC is projected to trade between $6.13 and $31.32, averaging $13.62 — a potential gain of +132% from today's $5.88. That is up +49% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in RGC today (≈ 170.068027 RGC) could be worth
$2,316.01
+$1,316.01 (+132%) by 2050 · US Dollar
Based on the average projected RGC price of $13.62 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in RGCwould be worth at today's price.
$1,000 invested in RGC on Jul 10, 2025 (≈ 60.368244 RGC) would be worth
$354.97
-$645.03 (-64.5%) today · 0.35× · US Dollar
Based on a RGC entry price of $16.57 vs. today's $5.88.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $6.37 | $923.08 | -7.7% |
| 1 month ago | $20.45 | $287.53 | -71.2% |
| 3 months ago | $28.82 | $204.02 | -79.6% |
| 6 months ago | $44.11 | $133.3 | -86.7% |
| 1 year ago | $16.57 | $354.97 | -64.5% |
| All time (5.0y) ago | $0.276316 | $21,279.98 | +2028.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our RGC forecast.
Our base-case forecast reaches $12.00 around 2050.
Implied market cap at $12.00: $5.93B
The 2026 forecast shows min $5.61, avg $6.00, max $8.00 with ROI 0 and sentiment NEUTRAL. In 2027, min $4.24, avg $5.85, max $8.72, ROI -2.4, sentiment NEUTRAL. In 2028, min $3.61, avg $5.28, max $8.39, ROI -11.8, sentiment NEUTRAL. In 2029, min $2.99, avg $4.61, max $7.69, ROI -23.1, sentiment BEARISH.
In 2030, min $3.19, avg $5.17, max $8.97, ROI -13.8, sentiment NEUTRAL. In 2031, min $3.76, avg $6.35, max $11.42, ROI 6, sentiment NEUTRAL. In 2032, min $4.23, avg $7.47, max $13.83, ROI 24.5, sentiment BULLISH. In 2033, min $3.98, avg $7.31, max $13.91, ROI 21.9, sentiment BULLISH.
In 2034, min $3.35, avg $6.41, max $12.51, ROI 6.9, sentiment NEUTRAL. In 2035, min $3.53, avg $7.01, max $14.01, ROI 17, sentiment NEUTRAL. In 2040, min $4.19, avg $9.31, max $20.44, ROI 55.3, sentiment BULLISH. In 2050, min $6.26, avg $13.90, max $31.98, ROI 131.9, sentiment BULLISH. These figures are estimates, not guarantees.
Tap a question to reveal the answer.
2030 avg $5.17, min $3.19, max $8.97; ROI -13.8%; sentiment NEUTRAL.
The near-term forecast is NEUTRAL (e.g., 2026 avg $6.00 and 2029 avg $4.61), while the longer term shows bullish years such as 2032 avg $7.47 and 2033 avg $7.31, and 2050 with avg $13.90 and ROI 131.9%.
Yes. The 2040 max is $20.44 and the 2040 avg is $9.31, so the forecast allows for a price above $10 in 2040.
Current price is $6.00. Market cap is $2.96B.
2050 min $6.26, avg $13.90, max $31.98; ROI 131.9%; sentiment BULLISH.
Regencell Bioscience Holdings Limited Community Discussion
0Share your Regencell Bioscience Holdings Limited price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.